Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Gibson Christopher sold 40,000 Recursion Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 5, 2026 · Filed Jun 5, 2026
On Jun 5, 2026, Gibson Christopher (Director) sold 40,000 Recursion Pharmaceuticals, Inc. shares at US$3.62 for US$145K under a trading plan, leaving 883,735 shares. Filed Jun 5, 2026 (Form 4).
- Sold
- 40,000 shares
- Price
- US$3.62
- Value
- US$145K
- Holding after
- 883,735 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Class A Common Stock | Conversion | 40,000 | 923,735 | Direct | |
| Jun 5, 2026 | Class A Common Stock | Sale | 40,000 | US$3.62 | 883,735 | Direct |
Source
Related
- Recursion Pharmaceuticals, Inc.
- Gibson Christopher
- Recursion Pharmaceuticals, Inc. shareholders
- Form 4 · Gibson Christopher · May 27, 2026
- Form 4 · Gibson Christopher · May 19, 2026
- Form 4 · Gibson Christopher · May 8, 2026
- Form 4 · Gibson Christopher · Apr 24, 2026
- Form 4 · Gibson Christopher · Apr 8, 2026
- Form 4 · Borgeson Blake · Oct 7, 2026
- Form 4 · Hershberg Robert · Oct 7, 2026
- Form 4 · Dar Zavain · Oct 2, 2026
- Form 4 · Li Dean Y · Oct 2, 2026
- Form 4 · Taylor Ben R · Sep 16, 2026